Asterias Biotherapeutics, Inc.
SEC CIK 1572552 · ASTY · last insider filing 2019-03-12
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Mulroy Michael H. | Director · President and CEO | filed 2017 - 2019 |
| Ricciardi Natale S | Director | filed 2014 - 2018 |
| Bailey DON M | Director | filed 2016 - 2018 |
| Cartt Stephen Lahue | Director · President and CEO | filed 2016 - 2018 |
| Lebuhn Richard T. | Director | filed 2014 - 2018 |
| Arno Andrew | Director | filed 2014 - 2018 |
| Scher Howard Isador | Director | filed 2016 - 2018 |
| Mohanty Aditya P. | Director | filed 2016 - 2016 |
| Kingsley Alfred D | Director | filed 2013 - 2016 |
| Peabody Robert | Director · Chief Financial Officer | filed 2013 - 2016 |
| Lichtinger Pedro | Director · President & CEO | filed 2014 - 2016 |
| Segall Judith | Director · Corporate Secretary | filed 2014 - 2015 |
| West Michael D | Director · VP of Technology Integration | filed 2013 - 2015 |
| Nordhoff Henry L | Director | filed 2013 - 2014 |
| VON Eschenbach Andrew C. | Director | filed 2013 - 2014 |
| Okarma Thomas | Director · President and CEO | filed 2013 - 2013 |
| Berger Franklin M | Director | filed 2013 - 2013 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Wirth Edward | Chief Medical Officer | filed 2015 - 2019 |
| Chavez Ryan Daniel | Exec. VP of Fin & Gen. Counsel | filed 2016 - 2019 |
| Spink Katharine E. | Vice President & COO | filed 2013 - 2017 |
| Lebkowski Jane | President of R&D | filed 2013 - 2017 |
| Erbez Georgia | Exec VP & CFO | filed 2015 - 2015 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.